These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 6888648)

  • 41. Metabolism of functional groups modifying the CNS myelin-associated glycoprotein.
    Toews AD; White FV; Morell P
    J Neurochem; 1988 Nov; 51(5):1646-50. PubMed ID: 2459313
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Aldose reductase activity and myo-inositol levels in sciatic nerve and dorsal root ganglia of the diabetic mutant mouse [C57/BL/Ks (db/db)].
    Llewelyn JG; Thomas PK; Mirrlees DJ
    Metabolism; 1991 Oct; 40(10):1084-7. PubMed ID: 1943734
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Posttranslational protein modification: biosynthetic control mechanisms in the glycosylation of the major myelin glycoprotein by Schwann cells.
    Poduslo JF
    J Neurochem; 1985 Apr; 44(4):1194-206. PubMed ID: 2579205
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Electrophoretic characterization of leucine, glucosamine- and fucose-labelled proteins rapidly transported in frog sciatic nerve.
    Edström A; Mattsson H
    J Neurochem; 1973 Dec; 21(6):1499-507. PubMed ID: 4358881
    [No Abstract]   [Full Text] [Related]  

  • 45. Incorporation in vivo of radioisotopic precursors into seromucoid proteins in streptozotocin diabetic rats.
    Guzdek A; Noworytko J; Sarnecka-Keller M
    Horm Metab Res; 1981 Sep; 13(9):491-4. PubMed ID: 7298017
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Regulation of myelination: biosynthesis of the major myelin glycoprotein by Schwann cells in the presence and absence of myelin assembly.
    Poduslo JF
    J Neurochem; 1984 Feb; 42(2):493-503. PubMed ID: 6198464
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Reduction of cyclic AMP in the sciatic nerve of rats made diabetic with streptozotocin and the mechanism involved.
    Shindo H; Tawata M; Onaya T
    J Endocrinol; 1993 Mar; 136(3):431-8. PubMed ID: 7682591
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Guanosine-5'-(3-O-thio)triphosphate-mediated stimulation of phosphoinositidase C in solubilized rat peripheral nerve myelin and its alteration in streptozotocin-induced diabetes.
    Mathew J; Eichberg J
    J Neurosci Res; 1994 Jan; 37(1):83-91. PubMed ID: 8145305
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Alterations in the sorbitol pathway and Na(+)-K(+)-ATPase activity of peripheral nerve of alloxan-induced diabetic rats].
    Lu KM; Zhong XL; Zhu XX; Zhu QY
    Sheng Li Xue Bao; 1990 Aug; 42(4):401-5. PubMed ID: 2175949
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Myelin protein transcripts increase in experimental diabetic neuropathy.
    Conti AM; Malosio ML; Scarpini E; Di Giulio AM; Scarlato G; Mantegazza P; Gorio A
    Neurosci Lett; 1993 Oct; 161(2):203-6. PubMed ID: 7505909
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The role of cyclic adenosine 3',5'-monophosphate and polyol metabolism in diabetic neuropathy.
    Shindo H; Tawata M; Aida K; Onaya T
    J Clin Endocrinol Metab; 1992 Feb; 74(2):393-8. PubMed ID: 1370506
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Supplemental myo-inositol prevents L-fucose-induced diabetic neuropathy.
    Sima AA; Dunlap JA; Davidson EP; Wiese TJ; Lightle RL; Greene DA; Yorek MA
    Diabetes; 1997 Feb; 46(2):301-6. PubMed ID: 9000708
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Insulin reverses enhanced incorporation of 32P into polyphosphoinositides in peripheral nerve of the streptozotocin diabetic rat.
    Berti-Mattera LN; Peterson RG; Eichberg J
    J Neurochem; 1986 Dec; 47(6):1932-5. PubMed ID: 3021909
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Purinergic signaling mediated by P2X7 receptors controls myelination in sciatic nerves.
    Faroni A; Smith RJ; Procacci P; Castelnovo LF; Puccianti E; Reid AJ; Magnaghi V; Verkhratsky A
    J Neurosci Res; 2014 Oct; 92(10):1259-69. PubMed ID: 24903685
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Accumulation of sorbitol in the sciatic nerve modulates circadian properties of diabetes-induced neuropathic pain hypersensitivity in a diabetic mouse model.
    Akamine T; Kusunose N; Matsunaga N; Koyanagi S; Ohdo S
    Biochem Biophys Res Commun; 2018 Sep; 503(1):181-187. PubMed ID: 29864425
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Glycoprotein biosynthesis in peripheral nervous system myelin: effect of tunicamycin.
    Smith ME; Sternberger NH
    J Neurochem; 1982 Apr; 38(4):1044-9. PubMed ID: 7062029
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Lysosomal delivery of the major myelin glycoprotein in the absence of myelin assembly: posttranslational regulation of the level of expression by Schwann cells.
    Brunden KR; Poduslo JF
    J Cell Biol; 1987 Mar; 104(3):661-9. PubMed ID: 2434515
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Retinoic acid increases tissue and plasma contents of nerve growth factor and prevents neuropathy in diabetic mice.
    Arrieta O; García-Navarrete R; Zúñiga S; Ordóñez G; Ortiz A; Palencia G; Morales-Espinosa D; Hernández-Pedro N; Sotelo J
    Eur J Clin Invest; 2005 Mar; 35(3):201-7. PubMed ID: 15733075
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Metabolism of a myelin-associated glycoprotein in developing rat brain.
    Druse MJ; Brady RO; Quarles RH
    Brain Res; 1974 Aug; 76(3):423-34. PubMed ID: 4853181
    [No Abstract]   [Full Text] [Related]  

  • 60. Glycoprotein biosynthesis during inflammation in normal and streptozotocin-induced diabetic rats.
    Sharma C; Dalferes ER; Radhakrishnamurthy B; Rosen EL; Berenson GS
    Inflammation; 1985 Sep; 9(3):273-83. PubMed ID: 3899928
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.